HIKMA PHARMACEUTICALS ORD GBP0.10 revenue for the last year amounted to 2.26 B GBP, the most of which — 967.78 M GBP — came from its highest performing source at the moment, Injectables, the year earlier bringing 926.30 M GBP. The greatest contribution to the revenue figure was made by United States — last year it brought HIKMA PHARMACEUTICALS ORD GBP0.10 1.39 B GBP, and the year before that — 1.16 B GBP.